One-Pager

Impella Heart Pump

Microaxial pumps for shock and high-risk PCI: signals, purge, alarms, care

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · Checked against current sources October 2026

Download one-page PDFLetter landscape, ready to print or keep with your notes

How it works

A catheter-mounted microaxial pump crosses the aortic valve, moving blood from the LV into the aorta. Flow is continuous, with no ECG or pressure trigger (unlike the IABP).

PumpAccessFlowLabeled use
CPFemoral or axillary artery3.3–3.7 L/min (peaks 4.3)HRPCI ≤6 h; shock ≤4 days
5.5Surgical axillary graft or aortaUp to 5.5 L/minShock ≤14 days; can walk
RP FlexIJ or femoral vein to PAAbout 4 L/minRV failure after LVAD, MI, transplant or surgery; ≤14 days

Who gets one

Indications: shock from isolated LV failure <48 h after MI or heart surgery, or from cardiomyopathy (including peripartum) or myocarditis, despite fluids, pressors and inotropes. Also high-risk PCI in stable patients (heart team decision).

Contraindications (left-sided pumps):

DanGer Shock (2024): in STEMI shock, Impella CP lowered 180-day mortality (46% vs 59%) but raised bleeding, limb ischemia and dialysis. 2025 ACC/AHA ACS guideline: microaxial pump class 2a in selected STEMI with severe or refractory shock; routine IABP class 3.

Reading the controller

P-levels (P-0 to P-9) set motor speed.

SignalCorrectMalpositioned
Placement signal (outlet sensor)Aortic waveformVentricular: outlet in LV, too deep
Motor currentPulsatile: inlet in LV, outlet in aortaFlat: whole pump in LV or in aorta
Echo (CP)Inlet 3.5 cm below the valveOver 4 cm deep, or inlet in aorta

Purge system

Pressurized purge fluid keeps blood out of the motor.

Alarms and first moves

AlarmLikely causeFirst moves
SuctionUnderfilled LV (volume, RV failure) or inlet on wallLower P-level; check volume, RV, position
Position in ventricle or in aortaWhole pump on one side of valveP-2; provider repositions with imaging
Placement signal lowOutlet at valve, too deep; motor current pulsatileAssess LV function; imaging; provider repositions
Purge pressure low (<300)Leak or dextrose too diluteFind leak; raise dextrose; new cassette
Purge pressure high (≥1100) or blockedKink or dextrose too strongUnkink; switch to D5W; watch motor current
Impella stoppedBackflow into LVRestart, or withdraw pump from LV

Complications and nursing care

Hemolysis causes: malposition, suction, underfilling, high P-level. First moves: confirm position by echo, fix filling, lowest P-level that supports the patient.
ComplicationWatch for
HemolysisDark, red or pink urine; falling Hgb; plasma free Hgb >40 mg/dL
Limb ischemiaCool, pale, pulseless leg; may need an antegrade perfusion sheath
BleedingSite hematoma; retroperitoneal flank pain, hypotension
AlsoAKI, stroke, valve or vessel injury, low platelets
Practice Impella Heart Pump questions free in your browser26 exam-style questions with rationales. No account or download needed.

In depth

The one-page summary above is what the PDF prints. These sections go further.

Hemodynamics in depth

The Impella is a continuous-flow axial pump in series with the LV: the inlet draws blood from the cavity and the impeller ejects it just above the aortic valve. Speed is fixed by the P-level, with no ECG or pressure trigger, so it pumps through VT, VF and asystole as long as the LV fills. An IABP adds about 0.5–1 L/min by displacement; a CP adds 3.5–4 L/min and a 5.5 up to 5.5 L/min of forward flow.

Unloading works at both ends of the coronary perfusion gradient: emptying the LV lowers LVEDP, PAOP and wall stress, so the pressure-volume loop shifts left and oxygen demand falls, while forward flow raises aortic diastolic pressure. Native ejection falls as support rises, so pulse pressure narrows; follow MAP, cardiac power output and LVEDP instead.

Flow at any P-level depends on the pressure difference across the pump, small in systole and large in diastole, so flow and motor current swing with every beat. The pump is preload dependent: hypovolemia, RV failure, tamponade or a large PE starve the inlet and cause suction. The RP Flex is the mirror image, moving blood from the right atrium to the pulmonary artery to lower CVP and raise LV preload; if the LV cannot accept the return, a left pump is needed too (BiPella).

Cardiac power output (W) = MAP × CO ÷ 451; below 0.6 W carried the highest mortality in the SHOCK trial registry (Fincke 2004). PAPi = (PA systolic − PA diastolic) ÷ RA pressure; below 0.9 with RA pressure above 12 mmHg points to RV failure that a left-sided pump cannot fix.

Device family and selection

The 2.5 (12 Fr) and surgical 5.0 (21 Fr) are earlier models; the 9 Fr expandable Impella ECP has finished its pivotal high-risk PCI study. All current pumps share the SmartAssist controller, purge cassette and P-0 to P-9 scale.
PumpMotor and shaftAccessFlow and US label
CP14 Fr motor, 9 Fr shaft, pigtail14 Fr peel-away; femoral or axillary3.7 L/min (peak 4.3); HRPCI 6 h, shock 4 days
5.519 Fr motor, 9 Fr shaft, no pigtail23 Fr peel-away via 10 mm axillary graft5.5 L/min; shock 14 days
RP Flex22 Fr cannula, 11 Fr shaft, 6 Fr pigtail23 Fr peel-away; right IJ or femoral veinAbout 4 L/min; RV failure 14 days

The CP is for support in minutes: AMI shock, high-risk PCI, a bridge to a decision. The 5.5 is for more flow or more time: post-cardiotomy shock, myocarditis, chronic heart failure bridged to LVAD or transplant, or an upgrade from a CP; the axillary route frees the groin and lets the patient walk. The RP Flex is for isolated RV failure after LVAD, RV infarct, transplant or cardiac surgery, or joins a left pump when CVP climbs and the left pump keeps sucking.

Insertion and position management

Femoral CP insertion: ultrasound-guided puncture of the common femoral artery, an angiogram to size the vessel (ideally ≥6 mm), pre-close sutures before the 14 Fr peel-away sheath, a 0.018-inch wire placed in the LV through a diagnostic catheter, the pump advanced over it under fluoroscopy and started at P-2. The peel-away sheath is then split off and the repositioning sheath advanced, leaving the 9 Fr shaft in the artery. The 5.5 needs a cutdown and a 10 mm graft on the axillary artery under TEE; the RP Flex passes from the right IJ or femoral vein through the tricuspid and pulmonary valves to the main PA.

Position is confirmed two ways. Fluoroscopy: inlet below the aortic annulus, pigtail free in the LV, cannula off the septum. Echo (parasternal long axis): annulus-to-inlet distance 3.5 cm for the CP and 5 cm for the 5.5, pump pointing at the apex, nothing caught in the mitral chordae. Record the shaft marker number at the sheath hub every shift.

Pumps migrate. Inward (hip flexion, coughing, a loosened sheath) puts the inlet against the wall or mitral apparatus: suction, hemolysis, a damped motor current. Outward (tension on the shaft, turning, transport) brings the outlet toward the valve: Placement Signal Low, then an in-ventricle or in-aorta alarm, finally a flat current. The nurse catches the change in marker, signal shape or flow and calls; only a credentialed clinician repositions, under echo or fluoroscopy, at P-2 during the move.

The SmartAssist screen

The home screen shows the alarm banner (red critical, yellow serious, white advisory), P-level and Impella flow, the placement signal and motor current waveforms, and purge and power status. The placement signal comes from an optical pressure sensor at the outlet; on the CP and 5.5 it is an aortic pressure, so it doubles as a second arterial line. From that pressure and the gradient implied by motor current the controller reconstructs LV pressure and displays LVEDP; entering a thermodilution or Fick cardiac output adds cardiac power output and native cardiac output (entered CO minus Impella flow).

ValueNormalWhat a change means
Placement signalAortic shape, dicrotic notch; MAP ≥65Ventricular shape: outlet in LV; damped: weak LV
Motor current (mA)Pulsatile, swings with each beatFlat: both ends in one chamber; slow rise: thrombus
Impella flowSteady for the P-level (CP P-8 about 3.3–3.5)Lower: MAP up, suction, malposition, clot
LVEDPFalling toward 10–18 mmHg>20 under-unloaded; <8 with suction: dry
Purge pressure300–1100 mmHg<300 leak or dilute; >1100 kink, clot, strong

Read the waveforms together. Aortic placement signal plus pulsatile current: the pump straddles the valve. Ventricular placement signal (low diastolic, wide swing) with pulsatile current: the outlet has slipped into the LV. Flat current: both ends are in one chamber, and the placement signal tells you which. A weak LV, arrest or VA-ECMO dampens both and produces Impella Position Unknown: examine the patient and get an echo. Flow is calculated, not measured, so it is wrong whenever the pump is malpositioned; a fall in flow at the same P-level is afterload, suction, malposition or clot until proven otherwise.

Troubleshooting alarm by alarm

AlarmCheckAction
SuctionVolume, CVP, bleeding; echo LV size and positionDown 1–2 P-levels; fill or support the RV; reposition
Position In Ventricle / In AortaBoth waveforms; marker at hub; echoP-2; provider repositions under imaging
Purge Pressure Low (<300)Luers, cassette, empty bag, dextrose strengthFix leak; new bag; raise dextrose (D5 to D20)
Purge Pressure High (>1100)Kinks, clamps, dextrose strength, clot in motorUnkink; lower dextrose (D20 to D5); watch current
Purge Flow Decreased / IncreasedTrend of pressure and flow over hoursPressure up with flow down: thrombus risk, call
Impella StoppedCable, controller, catheter faultRestart or backup controller; else P-0 and withdraw

Suction means the inlet cannot get blood: the LV is empty (hypovolemia, bleeding, RV failure, tamponade, vasodilation) or the inlet is on the wall. Raising the P-level pulls harder on an empty chamber; drop one or two levels and fix the filling. Suction with rising CVP and falling PAPi is the RV (inotropes, pulmonary vasodilators, RP Flex); suction with hemolysis and a damped current is position.

Purge alarms follow one rule: at a fixed viscosity, pressure tracks resistance. Low pressure means fluid is escaping (loose luer, cracked cassette, empty bag) or is thinner than expected; high pressure means a kink, a closed clamp, thicker fluid, or protein and thrombus narrowing the purge gap in the motor. The controller adjusts purge flow between 2 and 30 mL/h to hold pressure, so a slow pressure rise with falling flow over a shift is the earliest sign of pump thrombosis. Call the MCS coordinator or perfusion for a purge alarm a kink check does not clear, the interventionalist for a position alarm, and Abiomed's Clinical Support Center (1-800-422-8666, 24 hours).

Complications

Hemolysis is shear injury in the impeller; its drivers are the suction list plus speed: inlet near a wall or the chordae, an underfilled LV, a high P-level in a small cavity, thrombus on the impeller. Recognize it by pink or dark urine, plasma free hemoglobin above 40 mg/dL (IBCC), rising LDH and bilirubin, low haptoglobin, and a falling hemoglobin without bleeding. Free hemoglobin scavenges nitric oxide and clogs tubules, so AKI follows; renal replacement therapy was needed in 41.9% of Impella patients versus 26.7% of controls in DanGer Shock. Management: echo the position first, then the lowest P-level that holds MAP and CPO, volume, the purge pressure trend for thrombus, and an upgrade to a 5.5 or removal if it persists.

Limb ischemia follows from a 14 Fr sheath in a common femoral artery of 6–7 mm, less in women, diabetics and peripheral disease; DanGer Shock recorded it in 5.6% of Impella patients versus 1.1% of controls. Prevention: ultrasound and angiographic sizing, downsizing to the repositioning sheath, and in small vessels a prophylactic antegrade perfusion sheath (5–7 Fr in the superficial femoral artery, fed from the introducer side arm). Assess hourly: Doppler at the dorsalis pedis and posterior tibial, color, temperature, capillary refill, motor and sensory function, calf tension; near-infrared oximetry on both calves falls before pulses disappear. Treatment escalates from a perfusion sheath or external bypass, to thrombectomy or fasciotomy, to removing the pump or moving to the axillary artery.

Bleeding comes from the access site, the retroperitoneum when the puncture was above the inguinal ligament (flank pain, falling hemoglobin, clean groin), the GI tract, and acquired von Willebrand syndrome from shearing of the large vWF multimers; new thrombocytopenia prompts a HIT workup because purge heparin is a continuous exposure. Aortic regurgitation worsens the longer the cannula sits across the valve, so serial echo looks at the valve as well as the position. Stroke, pump thrombosis (rising purge pressure and motor current, falling flow), site infection and ventricular arrhythmias complete the list; a patient in sustained VT with a working pump can keep a MAP of 65 mmHg, so treat per ACLS and drop the P-level only if suction alarms.

ECMO plus Impella (ECPELLA)

Peripheral VA-ECMO returns blood retrograde up the aorta, raising LV afterload when the LV is least able to eject: the ventricle distends, the aortic valve stops opening, blood stagnates in the LV and root, and the lungs flood. An Impella across the valve vents the LV directly; the combination is ECPELLA. In 255 propensity-matched pairs (Schrage, Circulation 2020) unloading was associated with lower 30-day mortality (HR 0.79, 95% CI 0.63–0.98) at the price of more severe bleeding (38.4% vs 17.9%), access-site ischemia (21.6% vs 12.3%) and renal replacement therapy (58.5% vs 39.1%). The randomized UNLOAD ECMO trial is still enrolling.

The console reads differently on ECMO: aortic pressure is set by the ECMO pump, so the placement signal is a near-flat line at the MAP; the LV is small, so motor current loses its swing and Impella Position Unknown is common; and flow at a given P-level is lower because the pump works against a higher aortic pressure. The target is the lowest P-level that keeps the LV decompressed: a pulse pressure on the arterial line, the aortic valve opening on echo, LVEDP or PAOP below about 18 mmHg, no new pulmonary edema. Too much Impella empties the LV (suction, hemolysis); too little leaves it distended with echo contrast and thrombus.

Two traps. With femoral VA-ECMO and failing lungs the Impella pumps blood that has passed through the lungs to the coronaries and brain before the ECMO blood reaches them, so it delivers hypoxemic blood to the organs that matter most (north-south syndrome): monitor a right radial ABG and fix oxygenation first. Anticoagulation is one system: purge heparin counts toward the dose and a HIT diagnosis changes both circuit and purge. Weaning is usually ECMO first, leaving the Impella as the LV bridge.

Daily care, weaning and explant

Weaning starts when the cause has been treated and the numbers hold without escalation: MAP ≥65 mmHg on no or low-dose vasopressors, CPO >0.6 W, lactate cleared, LVEDP or PAOP under about 18 mmHg, urine output back, and an echo showing improving ejection. The CP comes down 2 P-levels at a time (the 5.5 one level), with 15–60 minutes or longer between steps depending on the program. Most programs hold at P-2 for 30 minutes to a few hours before explant; the IFU calls all of this guidance only.

For a femoral CP the interventionalist pulls the pump into the descending aorta at P-2, sets P-0 and removes the catheter; the sheath comes out when ACT is below 150 s, with 40 minutes of manual pressure per the IFU or closure of the pre-placed sutures, then about 6 hours of bedrest with the leg straight. The 5.5 comes out through the graft, which is then ligated; the RP Flex like a large venous sheath. Afterward: neurovascular checks every 15 minutes for an hour, then hourly; watch for hematoma, pseudoaneurysm and retroperitoneal bleeding; LDH and creatinine lag the pump by a day or two.

Evidence and controversies

TrialPatientsComparisonMain result
ISAR-SHOCK 200826 AMI shockImpella 2.5 vs IABPCI +0.49 vs +0.11 L/min/m²; 30-d death 46% both
PROTECT II 2012452 high-risk PCIImpella 2.5 vs IABP30-d MAE 35.1% vs 40.1% (NS); 90-d 40.6% vs 49.3%
IMPRESS 201748 AMI shock, 92% post-arrestImpella CP vs IABP30-d death 46% vs 50%; major bleeding 33% vs 8%
NCSI 2022 (registry)406 AMI shockImpella before PCI by protocol71% survival to discharge
DanGer Shock 2024360 STEMI shockImpella CP vs standard care180-d death 45.8% vs 58.5% (HR 0.74); harms 24.0% vs 6.2%

DanGer Shock is the first randomized trial to show a survival benefit for any mechanical support device in cardiogenic shock. Number needed to treat at 180 days was about 8; number needed to harm for the composite of severe bleeding, limb ischemia, hemolysis, device failure or worsening aortic regurgitation was about 6, and dialysis rose from 26.7% to 41.9%. It succeeded where IMPRESS failed by enrolling STEMI with lactate ≥2.5 mmol/L and LVEF <45%, excluding comatose arrest survivors, RV failure and mechanical complications, and placing the pump before or during PCI. The 2025 ACC/AHA ACS guideline made this a class 2a recommendation for a microaxial pump in selected STEMI patients with severe or refractory shock, with class 3 for routine IABP. VA-ECMO showed no survival benefit in ECLS-SHOCK (2023: 30-day death 47.8% vs 49.0%), and PROTECT II was stopped for futility, so high-risk PCI support rests on weaker evidence.

Still open: whether the benefit extends to NSTEMI, non-ischemic shock or arrest survivors; whether centers without a limb-protection and hemolysis protocol can reproduce the net benefit; and how to weigh the registries that found more death and bleeding with Impella than IABP (Dhruva 2020: in-hospital death 45.0% vs 34.1% in 1,680 matched pairs). PROTECT IV (high-risk PCI) and UNLOAD ECMO are still enrolling. Practice also varies on heparin versus bicarbonate purge and on ACT 160–180 s per IFU versus aPTT or anti-Xa targets.

Exam pearls

Practice free in your browser3,800+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.

Related one-pagers

Sources

  1. Abiomed (Johnson & Johnson MedTech). Impella CP with SmartAssist for Use During Cardiogenic Shock and High-Risk PCI: Instructions for Use and Clinical Reference Manual (US), V11.1, Document No. 0048-9007 rV, February 2026. Link
  2. Abiomed (Johnson & Johnson MedTech). Impella 5.5 with SmartAssist for Use During Cardiogenic Shock: Instructions for Use and Clinical Reference Manual, Document No. 10003049 rL, February 2026. Link
  3. Abiomed (Johnson & Johnson MedTech). Impella RP Flex with SmartAssist System: Instructions for Use and Clinical Reference Manual (US), Document No. 10003286 Rev. J, April 2026. Link
  4. HeartRecovery.com (Abiomed). Impella Important Safety Information, accessed October 2026. Link
  5. HeartRecovery.com (Abiomed). Impella CP with SmartAssist product page, accessed October 2026. Link
  6. HeartRecovery.com (Abiomed). Impella 5.5 with SmartAssist product page, accessed October 2026. Link
  7. HeartRecovery.com (Abiomed). Impella RP Flex with SmartAssist product page, accessed October 2026. Link
  8. Johnson & Johnson MedTech. Impella heart pumps product page, accessed October 2026. Link
  9. Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025;151(13):e771-e862. doi:10.1161/CIR.0000000000001309. PMID 40014670. Link
  10. TCTMD. ACC/AHA Release New Comprehensive ACS Guidelines. February 27, 2025. Link
  11. American College of Cardiology. Cardiogenic Shock and Mechanical Circulatory Support: Year in Review 2025. August 2026. Link
  12. Zein R, Patel C, Mercado-Alamo A, Schreiber T, Kaki A. A Review of the Impella Devices. Interv Cardiol. 2022;17:e05. Link
  13. Farkas J. Impella. Internet Book of Critical Care (EMCrit), updated October 14, 2024. Link
  14. AACN Certification Corporation. CCRN Exam Handbook, Direct Care, July 2026 (Adult CCRN test plan for exams on and after November 12, 2025). Link
  15. Stony Brook Medicine. Procedure for anticoagulation with heparin for patients with an IMPELLA device (not on ECMO), January 17, 2019. Link